Other languages Trevena, Inc.

Equities

TRVN

US89532E2081

Market Closed - Nasdaq Other stock markets 01:30:00 27/04/2024 am IST			5-day change	1st Jan Change
0.391 ^USD	-4.40%		+11.08%	-45.85%

01/04	Trevena, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
01/04	Trevena, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Trevena, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	01/04
Trevena, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	01/04
Trevena, Inc. Promotion of Barry Shin to the Position of Executive Vice President and Chief Operating Officer	01/02
Trevena Raises $4 Million via Placement, Warrant Exercise	29/12
Trevena to Raise $4 Million From Private Placement, Warrants Exercise Agreements	27/12
Trevena Inc. Receives OLINVYK Agreement with Premier, Inc	04/12
Trevena Files $200 Million Mixed Shelf	04/12
Trevena, Inc. Announces Acceptance of Abstract Examining the Use of Olinvyk in Patients with Acute Burn Injuries	30/11
Trevena, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
Trevena, Inc. Announces Board Changes	10/11
Trevena, Inc. Announces Completion of Initial Analysis of Olinvyk Continuous Respiratory Monitoring Data from Volition Study	02/23/02
Trevena, Inc. Announces Retirement of Michael Dougherty as A Member of the Board of Directors and as A Member of the Audit Committee, Effective as of September 14, 2023	19/23/19
Top Premarket Gainers	06/23/06
Trevena, Inc. Announces Preliminary TRV045 Data from Two Proof-Of-Concept Studies Evaluating S1pr Mechanism of Action and CNS Target Engagement	06/23/06
Trevena, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/23/14
Trevena, Inc. Appoints Mark Corrigan to Board of Directors	21/23/21
Trevena, Inc. Announces New Topline OLINVYK Data Highlighting Reduced Cost Per Admission from Artemis Real-World Outcomes Study	26/23/26
Expected House Vote on Debt Ceiling Deal Weighs on Sentiment, Pushing US Equity Futures Lower	31/23/31
Trevena Receives $3 Million Milestone Payment From Partner Jiangsu Nhwa Pharmaceutical	31/23/31
Top Premarket Gainers	31/23/31

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Trevena, Inc.

Equities

TRVN

US89532E2081

Other languages

Filters